BMJ Open (May 2021)

Tai Chi postural training for dyskinesia rehabilitation: a study protocol for a randomised controlled trial in convalescent ischaemic stroke patients

  • Yong Zhang,
  • Zhe Zhang,
  • Li Zhou,
  • Mingzhi Zhao,
  • Yingjie Li,
  • Zongheng Li,
  • Chengyang Jing,
  • Kuangshi Li,
  • Yiting Sun,
  • Jiabao Wu,
  • Yuyue Li

DOI
https://doi.org/10.1136/bmjopen-2020-046003
Journal volume & issue
Vol. 11, no. 5

Abstract

Read online

Introduction Acute ischaemic stroke (AIS) is not only seriously damaging to the physical and mental health of patients, but also has become a major social public health problem. Effective dyskinesia rehabilitation treatment in convalescence is of great significance for AIS patients’ prognosis and quality of life. Tai Chi (TC) shows great potential in improving motor function. This trial aims to evaluate the clinical efficacy of modified TC postural training (TPT), and to explore the related central-peripheral neurotransmitter mechanisms.Methods/design The proposed study will be a multicentre randomised controlled trial. The trial will randomise 120 eligible AIS patients in a 1:1 ratio to receive TPT or Bobath rehabilitation training. Each training session will last 40 min and will be implemented once a day and five times per week (from Monday to Friday) in a duration of 4 weeks. After finishing the 4-week treatment, another 3-month follow-up period will be seen. Root mean square generated from the surface electromyogram (sEMG) will be the primary outcome. Other sEMG time-domain parameters and frequency-domain parameters and clinical scales assessment will be the secondary outcomes. Peripheral blood samples will be collected at baseline and at the end of 4-week treatment, which will be used to explore the related therapeutic mechanisms. Intention-to-treat analysis and per-protocol analysis will both be implemented in this trial.Ethics and dissemination The study has been approved by Ethics Committee of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, being granted approval numbers DZMEC-KY-2020–22. The research results will be disseminated through (open access) peer-reviewed publications and presentations at conferences.Trial registration number ChiCTR2000032999.